In cohort I, the results for the expression of the genes involved in immune response suppression in the tumor microenvironment showed that immunization with the vaccine with glucomannan at the 2 mg dose suppressed Foxp3 gene expression compared to the lysate vaccine and PBS group (p = 0.1508 and p = 0.0079, respectively). Here, FOXP3 is linked to neoplasm.